GleamWall
中文EN

ACOG Alpha Cognition Inc.

Biological Products, (No Diagnostic Substances) · Nasdaq · SEC CIK 1655923 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-48.6%
TTM EPS YoY8.5%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin99.8%
Operating margin-149.6%
Net margin-147.3%
FCF margin-152.7%
EBITDA margin-148.2%

Returns

ROE-74.2%
ROA-53.9%
ROIC (approx.)-696.4%
Asset turnover0.37x

Leverage & solvency

Liabilities / assets22.9%
Debt / equity0.00x
Current ratio7.13x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.02x
Accruals ratio1.2%
Payout ratio—
Capex / revenue2.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$10.22M—
Cost of revenue$603,400—
Gross profit$9.62M—
R&D expense$1.87M$3.92M
SG&A expense$29.08M$8.01M
Operating income-$22.66M-$12.01M
Interest expense—$105,273
Pretax income-$9.34M-$621,897
Net income-$20.67M-$14.79M
EBITDA-$22.60M-$11.93M
EPS (basic)-1.17-2.04
EPS (diluted)-1.18-2.04
Weighted avg. shares (diluted)17.68M7.25M
Banking
Provision for credit losses—$55,000
Balance sheet
Cash & equivalents$66.05M$48.56M
Receivables$4.24M—
Inventory$5.12M$615,133
Current assets$79.01M$50.25M
PP&E, net$328,540$27,077
Intangibles$391,423$412,969
Total assets$79.73M$50.74M
Current liabilities$9.13M$3.35M
Total liabilities$17.20M$11.64M
Shareholders' equity$62.53M$39.09M
Shares outstanding21.74M16.02M
Cash flow statement
Operating cash flow-$20.38M-$7.76M
Capital expenditure$293,489$26,701
Free cash flow-$20.67M-$7.78M
Investing cash flow-$293,489-$26,701
Financing cash flow$38.21M$54.85M
Depreciation & amortization$58,572$81,220
Stock-based compensation$4.92M$1.13M

Free plan shows the latest 2 periods; Pro shows all 3 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.